A clinical study of MK-1289 in healthy adult men (MK-1289-001)
MK-1289-001
Phase 1 other active
Quick answer
A clinical study of MK-1289 in healthy adult men (MK-1289-001) for COVID-19 Infection is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- COVID-19 Infection
- Phase
- Phase 1
- Modality
- other
- Status
- active